Unproven for older women, digital mammography saps Medicare dollars

By Joe Eaton, Elizabeth Lucas and David Donald

High-tech, digital mammography may not be any better at detecting breast cancer in women over 65 than older film-based systems, but Medicare

Related to this story

Digital mammography no better than film for most women, despite increased costs

By Joe Eaton

Data analysis on digital mammography Medicare claims

By David Donald and Elizabeth Lucas

Research methodology

By David Donald and Elizabeth Lucas

Landmark diesel exhaust study stalled amid industry and congressional objections

By Jim Morris

Excerpts from this story referencing "The New England Journal":

"… n older women than film mammograms. The trial, which was first reported in The New England Journal of Medicine, was one of the largest to-date to compare digital to film mam …"

FDA: A shell of its former self

By M. Asif Ismail

The Food and Drug Administration lacks the power to regulate pharmaceuticals and keep you safe

Related to this story

Most drug trial results analyzed by FDA hidden from view

By Naseem Miller

A record year for the pharmaceutical lobby in '07

By M. Asif Ismail

Drug industry influence timeline

By The Center for Public Integrity

Lack of adequate foreign drug oversight

By The Center for Public Integrity

Excerpts from this story referencing "Thalomid":

"… xander Cohen, Kevin Boettcher and Emily McNeill contributed to this report. …"

"… Corp. In fact, the global pharmaceutical company's Web site proclaims that Thalomid is "the current driver of Celgene revenue growth."According to the Food an …"

"… lso oversees their development, manufacturing, marketing and distribution, Thalomid (the brand name version of thalidomide, which in the early 1960s was presc …"

"… may prescribe it for other conditions. A Celgene spokesperson admits that Thalomid is most often for off-label uses, rather than the leprosy condition.As the …"